Skip to main content
. 2022 May 19;41:24–34. doi: 10.1016/j.euros.2022.04.011

Fig. 2.

Fig. 2

Decision curve analysis comparing the net benefit associated with the use of our combinations of preoperative parameters of interest versus the EAU risk classification systems in predicting the (A) risk of BCR and (B) metastatic recurrence at 5 yr. BCR = biochemical recurrence; EAU = European Association of Urology; %GP4/5 = percentage of Gleason patterns 4 or 5; MCCL = maximum cancer core length; PSA = prostate-specific antigen.